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The aim of this paper is to present clinicopathologic features and immunohistochemical ﬁndings of a primary leiomyosarcoma of
bone occurring in the proximal femur of a 46-year-old Caucasian male patient. Each case report on this exceedingly rare entity
contributes to the notion of this disease.
1.Introduction
Sarcomas comprise a heterogeneous group of mesenchymal
neoplasm. The vast majority of so-called smooth-muscle
tumors arise in the uterus, gastrointestinal tract, mesentery,
and omentum [1]. Leiomyosarcomas are malignant smooth-
muscle tumors composed of spindle cells showing distinct
smooth muscle features that exceedingly rarely occur in the
bone [2, 3]. Despite of an unknown aetiology, they typically
occur in middle-aged or older persons [1]. Leiomyosarcoma
of the bone is reported to occur predominately in male
adults, particularly in large bones, most commonly in the
distal femur [4]. First reported by Evans and Sanarkin in
1965 [3], this entity is thought to arise from the vascular
smooth-muscle cells within the bone [4].
Fornonretroperitonealsofttissueleiomyosarcomas,local
recurrences and metastases usually occur within the ﬁrst few
years after initial diagnosis and commonly metastasize to the
lungs. Prognosis depends on the location, stage, and grade
of the primary tumor as well as the presence of metastatic
disease [1].
Herein we present clinicopathologic features and im-
munohistochemical ﬁndings of a primary leiomyosarcoma
of bone occurring in the proximal femur of a 46-year-old
Caucasian male patient.
2. Case Presentation
A 46-year-old Caucasian man was admitted to our depart-
ment due to pain in his right proximal thigh. Medical history
revealed no contributory family and past histories, and no
neurological deﬁcits were detected by physical examination.
X-rays and MRI presented an expanding 10cm lytic
lesion with an inhomogeneous contrast medium enhance-
ment occupying the right proximal femur and extended into
the proximal shaft (Figure 1). The lesion showed amorphous
density resulting from a high-grade destruction of the
cancellous bone. A perforation of the osseous cortex with
an adjacent extraosseous mass was detected. Subsequently
performed tumor staging including soft tissue scans of chest,
abdomen, and pelvis gave no evidence of metastatic disease
or evidence of another primary tumor.
Biopsy specimen revealed a malignant mesenchymal
fascicular spindle cell proliferation with smooth-muscle
diﬀerentiation reﬂected by the expression of a-SMA (a-
smooth-muscle-actin), desmin, and caldesmon by immuno-
histochemistry. The patient underwent limb salvage surgery
followed by endoprosthetic replacement (Figure 1). Wide
surgical margins were achieved and after a 23-day inpatient
stay, the patient was discharged from hospital with postop-
erative chemotherapy according to the EUROBOSS study
protocol.
The explant consisted of a 25cm long proximal femur
(Figure 2)witha10cmtumorinlargestdiameterthatmainly
occupiedthemedullarycavity.Anareaofcorticalperforation
with an extraosseous soft tissue mass of 2cm was seen. The
tumor showed a grey-white cutting surface (Figure 2).
The histological evaluation revealed a malignant fasci-
cular spindle cell proliferation with an inﬁltrative growth
pattern composed of interweaving fascicles. The tumor cells2 Case Reports in Medicine
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Figure1:Radiographsofthepatient’srightfemur:(a)preoperative,
an expanding lytic lesion (10cm in max. diameter) located in the
right proximal femur with extension into the proximal shaft, (b)
two months after limb salvage surgery followed by endoprosthetic
replacement.
Figure 2: The explant shows a proximal femur measured 25cm in
length, a tumor of 10cm in max. dimension and predominantly
grey-white appearance occupies the medullary cavity.
were spindle shaped, elongated, blunt ended, hyperchro-
matic, focally pleomorphic, and surrounded by a prominent
eosinophiliccytoplasm(Figure 3).Withantibodiesagainsta-
SMA, desmin, and caldesmon the majority of the tumor cells
showed a speciﬁc positive reaction. Immunohistochemistry
usingantibodiesdirectedagainstCytokeratinandS-100were
negative (Figure 3). In the area of the previous biopsy site a
spot of 0.2mm of cartilaginous diﬀerentiation was found.
After one year of followup, a successfully performed one-
stage revision surgery became indispensable due to a late-
onset infection of the primary prosthesis. For more than
9 months of followup after ﬁrst surgery no evidence of
metastatic disease or local recurrence was seen. Although
two 2mm lesions were detected in both lungs by soft tissue
scans the lesions did not show any progression during the
following 16 month of followup.
3. Discussion
Primary leiomyosarcoma of bone is exceedingly rare,
accounting for less than 0.7% of all primary malignant
bone tumors [5]. It most commonly occurs in male adults,
particularly in large bones like the distal femur [3, 6, 7].
Although prognosis has been diﬃcult to deﬁne due to its
rarity, most studies have indicated that these tumors are of
an aggressive nature [8].
As primary leiomyosarcoma of bone is exceptionally rare
weconsideredthefollowingdiﬀerentialdiagnoses.Firstofall
skeletal metastases from a primary leiomyosarcoma located
in the gastrointestinal tract or soft tissues were excluded by
CT scans and scintigraphy using the diagnostic guidelines
described by Antonescu et al. [9].
In addition low-grade intramedullary osteosarcoma,
ﬁbrosarcoma of bone, and metastases of a spindle cell car-
cinoma were excluded by means of morphological analysis
and immunohistochemistry.
Based on a 0.2mm area of cartilaginous diﬀerentiation
ad e d i ﬀerentiated chondrosarcoma (DCS) was considered as
anotherdiﬀerentialdiagnosis.DCSisdeﬁnedbythepresence
of a well-diﬀerentiated cartilaginous component with abrupt
transition in a dediﬀerentiated tumor component, which
may have features of pleomorphic sarcoma, NOS (malig-
nantﬁbroushistiocytoma,osteosarcoma,ﬁbrosarcoma),and
exceptional rarely leiomyosarcoma [10]. Typically DCS is
seen in older individuals than in the patient presented
herein, with an average age between 50 and 60 years [10].
DCS frequently has a typical radiological appearance with
a characteristic bimorphic radiological pattern reﬂecting the
two diﬀerentiation levels of the tumor [11]. Herein, imaging
examination revealed a malignant appearing, permeative
lytic lesion located near the metaphysic portion of the bone.
No radiological signs of a cartilaginous component in terms
of a bimorphic pattern or stippled calciﬁcations were seen as
they would have been expected in a DCS.
Approximately 90% of all patients with DCS have a poor
prognosis and die thus due to metastatic disease within the
ﬁrst two years after diagnosis [10, 12–14]. The small lesions
detected in the lungs of our patient were not growing over
a period of 16 months—suggesting that metastatic disease is
unlikely in our case.
The age of our patient, the radiologic appearance (lack of
a bimorphic pattern, lack of punctate or ring-like opacities)
as well as the fact that the 0.2mm area with cartilaginous dif-
ferentiation corresponded to the area of the previous biopsy
side prompted us to consider the cartilaginous component
as reactive, and therefore, the diﬀerential diagnosis DCS was
rejected.
We herein report clinicopathologic features and im-
munohistochemical ﬁndings of a primary leiomyosarcoma
of bone located in the proximal femur of a 46-year-old
Caucasian male patient. Each case report on this exceed-
ingly rare entity contributes to the notion of this disease.Case Reports in Medicine 3
(a) HE spindle cell proliferation with inﬁltrative
growth pattern
(b) Fascicles of spindle cells with blunt-ended nuclei
and eosinophilic cytoplasm
(c) Tumor cells with strong expression of SMA by
immunohistochemistry
(d) Tumor cells with strong expression of Desmin by
immunohistochemistry
Figure 3: Histologic workup of the tumor tissue: (a) HE, (b) HE, (c) SMA, (d) Desmin.
As the reported case shows, clinicians should be aware of
leiomyosarcoma of bone as diﬀerential diagnosis.
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